DETECTION OF A POINT MUTATION IN NQO1 (DT-DIAPHORASE) IN A PATIENT WITH COLON-CANCER

被引:25
作者
KOLESAR, JM
KUHN, JG
BURRIS, HA
机构
[1] BROOKE ARMY MED CTR,SAN ANTONIO,TX
[2] CANC THERAPY & RES CTR S TEXAS,SAN ANTONIO,TX 78229
关键词
D O I
10.1093/jnci/87.13.1022-a
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1022 / 1024
页数:3
相关论文
共 10 条
[1]  
HASHIMOTO H, 1995, CLIN CANCER RES, V1, P369
[2]  
JAISWAL AK, 1988, J BIOL CHEM, V263, P13572
[3]  
KOLESAR J, 1995, P AM J CLIN ONCOL, V14, P420
[4]   THE ROLE OF NAD(P)H - QUINONE OXIDOREDUCTASE IN MITOMYCIN C-RESISTANT AND PORFIROMYCIN-RESISTANT HCT 116 HUMAN COLON-CANCER CELLS [J].
PAN, SS ;
AKMAN, SA ;
FORREST, GL ;
HIPSHER, C ;
JOHNSON, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 (01) :23-31
[5]   CELLULAR PHARMACOLOGY OF QUINONE BIOREDUCTIVE ALKYLATING-AGENTS [J].
ROCKWELL, S ;
SARTORELLI, AC ;
TOMASZ, M ;
KENNEDY, KA .
CANCER AND METASTASIS REVIEWS, 1993, 12 (02) :165-176
[6]   DT-DIAPHORASE IN ACTIVATION AND DETOXIFICATION OF QUINONES - BIOREDUCTIVE ACTIVATION OF MITOMYCIN-C [J].
ROSS, D ;
SIEGEL, D ;
BEALL, H ;
PRAKASH, AS ;
MULCAHY, RT ;
GIBSON, NW .
CANCER AND METASTASIS REVIEWS, 1993, 12 (02) :83-101
[7]  
SIEGEL D, 1990, CANCER RES, V50, P7293
[8]  
SIEGEL D, 1995, P AM ASSOC CANC RES, V36, P1729
[9]  
TRAVER RD, 1992, CANCER RES, V52, P797
[10]   ACTIVATION OF AP-1 AND OF A NUCLEAR REDOX FACTOR, REF-1, IN THE RESPONSE OF HT29 COLON-CANCER CELLS TO HYPOXIA [J].
YAO, KS ;
XANTHOUDAKIS, S ;
CURRAN, T ;
ODWYER, PJ .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) :5997-6003